GDNA

Goldman Sachs Human Evolution ETF
*Unless otherwise stated, data provided by FactSet.

GDNA Fund Description

GDNA tracks a market-cap weighted index of global equities related to the development of medical treatments for overall human health.

GDNA Factset Analytics Insight

GDNA is centered around companies with exposure to “the development of new knowledge, medicines, and technologies for the medical treatment of the human condition, from birth to end-of-life care”. The fund’s index is constructed from five sub-themes: Precision Medicine, Genomics, Life Extension, Robotic Surgery, and Digital Health. To select its constituent securities, the index provider uses automated semantic search algorithms to go through many datasets and documents to generate company correlations to key terms related to GDNA’s theme. The top 120 stocks receiving a score are included in the index. Weighting is a mix of market cap and the above correlation that is generated, with a minimum weight of a 0.1% and a maximum of 5%. Prior to May 15, 2020 the index provider was Motif Capital Management. Goldman announced plans to consolidate this ETF with four of their other similar "theme" ETFs (GDAT, GFIN, GMAN, GBUY). The reorganization looks to occur around November 6, 2020.

GDNA MSCI ESG Analytics Insight

Goldman Sachs Human Evolution ETF has an MSCI ESG Fund Rating of A based on a score of 6.10 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. Goldman Sachs Human Evolution ETF ranks in the 54th percentile within its peer group and in the 46th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

GDNA MSCI FaCS and Factor Box

MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.

GDNA Charts And Performance

Price Chart ($)
Total Return Chart (%)
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
Compare
Reset
Select ETFs to compare their performance:
PERFORMANCE [as of 10/23/20] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
GDNA 5.57% 2.14% 18.95% 36.17% -- -- --
GDNA (NAV) 7.54% 11.51% 19.07% 27.48% -- -- --
Thomson Reuters Global Healthcare 3.08% 1.03% 9.55% 22.26% 11.37% 10.70% 13.41%
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

GDNA Summary Data

Goldman Sachs
03/01/19
Open-Ended Fund
0.50%
$63.38M
$409.52K
0.20%

GDNA Portfolio Data

$64.54B
-314.43
4.70
0.20%
12/24/20
112

GDNA Index Data

Goldman Sachs Human Evolution Index
Market Cap
Market Cap
Thomson Reuters Global Healthcare

GDNA Portfolio Management

0.50%
--
--
--

GDNA Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

GDNA Fund Structure

Open-Ended Fund
No
--
No Policy
N/A
N/A
Low
Daily
Cboe Book Viewer
Top Of Book
Last 10 Trades
Bats BZX Real-time Quote -

GDNA Factset Analytics Block Liquidity

As of 10/26/20
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of GDNA. GDNA is rated a 4 out of 5.

GDNA Tradability

6,413
$409.52K
2,555
$165.03K
0.20%
$0.13
0.15%
0.77% / -0.80%
None
--
25,000
0.10
--
0.04%
0
$66.95
4

GDNA Sector/Industry Breakdown


GDNA
Segment Benchmark
42.98%
29.33%
33.30%
10.36%
16.41%
47.62%
6.79%
12.66%
0.28%
--
0.24%
--

GDNA Top 10 Holdings[View All]

2.43%
2.42%
2.40%
30.94%

GDNA Countries


GDNA
Segment Benchmark
74.42%
64.37%
6.91%
2.18%
5.20%
1.72%
4.97%
3.89%
4.17%
8.79%
2.28%
1.90%
1.53%
6.73%
0.52%
1.99%
--
0.06%
--
0.06%

GDNA Regions


GDNA
Segment Benchmark
74.42%
64.56%
18.33%
20.99%
7.25%
13.98%
--
0.30%
--
0.17%

GDNA Economic Development


GDNA
Segment Benchmark
100.00%
97.99%
--
2.01%

GDNA Performance Statistics

0.90
1.19
1.11
1.19
0.62%
Thomson Reuters Global Healthcare

GDNA MSCI ESG Ratings

6.10 / 10
46.08
53.68
--
12.39%
25.54

GDNA Benchmark Comparison Holdings

112
880
100
31.41%

GDNA Benchmark Comparison Summary


GDNA
Segment Benchmark
112
880
$64.54B
$120.23B
-314.43
35.48
4.70
4.25
0.77%
1.65%
Low
Low

GDNA Benchmark Comparison Market Cap Size


GDNA
Segment Benchmark
63.80%
84.03%
21.86%
11.14%
13.43%
3.99%
0.92%
0.84%